Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.87 |
| ▸ | PPARG | P37231 | 6/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | PPARD | Q03181 | 5/20 | 0.63 |
| ▸ | PPARA | Q07869 | 5/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | FABP4 | P15090 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.63 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15323230 | 1.00 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL15323229 | 1.00 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL15377389 | 1.00 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL15335272 | 1.00 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL3754861 | 0.99 | MAPT (0.85) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL3754858 | 0.99 | MAPT (0.85) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL3752243 | 0.95 | MAPT (0.79) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL2508939 | 0.95 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL15335332 | 0.95 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA | |
| SCHEMBL2508938 | 0.95 | MAPT (0.87) | MAPTPPARGALDH1A1PPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107250-A1 | METHODS AND SYSTEMS FOR PROFILING FATTY LIVER DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-21 | — | — | WO | claimed |
| US-20250216407-A1 | LIVER DISEASE TREATMENT AND ASSESSMENT USING OXYLIPINS | INIPHARM, INC. | 2025-07-03 | — | — | US | claimed |
| CN-119069037-B | Detection method of heart failure detection biomarker based on oxidized lipid derivatization and machine learning model | 中国中医科学院医学实验中心 | 2025-02-14 | — | — | CN | claimed |
| EP-4468884-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | Amarin Pharmaceuticals Ireland Limited (IE) | 2024-12-04 | — | — | EP | claimed |
| CN-119069037-A | Detection method of heart failure detection biomarker based on oxidized lipid derivatization and machine learning model | 中国中医科学院医学实验中心 | 2024-12-03 | — | — | CN | claimed |
| CN-118714935-A | Lymphoreleased fatty acid compositions and their use for lymphatic incorporation and systemic disease treatment | 阿马里纳药物爱尔兰有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-117586945-B | Application of 14,15-EET in preparation of culture system | 浙江大学 | 2024-08-20 | — | — | CN | claimed |
| US-20240201207-A1 | METHOD AND KIT FOR PREDICTING PREECLAMPSIA | MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (DE) | 2024-06-20 | — | — | US | claimed |
| US-20240173285-A1 | COMPOSITIONS COMPRISING EPA AND METHODS OF USING THE SAME FOR TREATING AND/OR PREVENTING ENDOTHELIAL DYSFUNCTION IN A SUBJECT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2024-05-30 | — | — | US | claimed |
| EP-4329742-A1 | COMPOSITIONS COMPRISING EPA AND METHODS OF USING THE SAME FOR TREATING AND/OR PREVENTING ENDOTHELIAL DYSFUNCTION IN A SUBJECT | Amarin Pharmaceuticals Ireland Limited (IE) | 2024-03-06 | — | — | EP | claimed |
| WO-2023192314-A1 | LIVER DISEASE TREATMENT AND ASSESSMENT USING OXYLIPINS | INIPHARM, INC. (US) | 2023-10-05 | — | — | WO | claimed |
| US-20230284643-A1 | MILK PRODUCT COMPOSITIONS | BIOMILQ INC (US) | 2023-09-14 | — | — | US | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| WO-2023146984-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2023-08-03 | — | — | WO | claimed |
| WO-2023083380-A1 | METHOD FOR PREDICTING PROGNOSIS OF PATIENT WITH HEART FAILURE WITH ARACHIDONIC ACID METABOLOME DATA IN SERUM | 北京市心肺血管疾病研究所 | 2023-05-19 | — | — | WO | claimed |
| EP-4157990-A1 | MILK PRODUCT COMPOSITIONS | Biomilq, Inc. (US) | 2023-04-05 | — | — | EP | claimed |
| WO-2022232633-A1 | COMPOSITIONS COMPRISING EPA AND METHODS OF USING THE SAME FOR TREATING AND/OR PREVENTING ENDOTHELIAL DYSFUNCTION IN A SUBJECT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2022-11-03 | — | — | WO | claimed |
| WO-2022223542-A1 | METHOD AND KIT FOR PREDICTING PREECLAMPSIA | MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (DE) | 2022-10-27 | — | — | WO | claimed |
| EP-4080220-A1 | METHOD AND KIT FOR PREDICTING PREECLAMPSIA | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (DE) | 2022-10-26 | — | — | EP | claimed |
| US-7214495-B2 | Screening method | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-05-08 | — | — | US | claimed |